Introduction {#sec1-1}
============

Arthritis and tenosynovitis of the hock and stifle joints are the most common skeletal affections in breeder chicken, in addition to spondylitis and osteomyelitis lesions \[[@ref1]\]. Arthritis is a worldwide welfare issue in poultry production, caused by many bacterial and viral pathogens. Of those bacterial pathogens, *Mycoplasma synoviae* (MS), *Salmonella* spp., *Escherichia coli*, *Staphylococci*, and *Enterococcus* have been isolated from clinical cases of arthritis \[[@ref2]-[@ref5]\].

As mentioned above, MS is one of the most important bacterial pathogens causing arthritis. It is a worldwide economically important pathogen of poultry, causing respiratory affections, synovitis, abnormalities in eggshell, and drop in production in chickens and turkeys \[[@ref6]-[@ref9]\]. Mostly, MS infections are subclinical with lesions confined to air sac. While in the case of combination with secondary infections, MS becomes systemic and affects the synovial membrane of joints and tendon causing acute and chronic infectious synovitis \[[@ref10]-[@ref12]\]. Birds suffering from infectious synovitis are depressed, reluctant to walk with lameness, and affected hock joints are swollen and hot. The synovial membranes of tendon sheaths become thickened, edematous, with fibrinous exudates accumulation within and around the tendon sheaths \[[@ref4]\]. MS is transmitted laterally and vertically, with lateral transmission through direct contact with infected carrier birds and fomites \[[@ref13]\]. MS infection in poultry flocks can be diagnosed either serologically, mainly done by serum plate agglutination (SPA) and hemagglutination inhibition, or through direct microbial isolation and identification that represent the gold standard, but time-consuming due to long incubation and fastidious nature of mycoplasmas \[[@ref6]\]. Recently, molecular diagnosis with a polymerase chain reaction (PCR) is commonly used \[[@ref14]-[@ref16]\]. SPA test is quick, inexpensive, and sensitive test used for serological screening for *Mycoplasma* spp. and *Salmonella* spp. \[[@ref17]\]. The *vlhA* gene of MS encodes for hemagglutinin and other immunodominant membrane proteins involved in colonization, antigenic variations, and virulence. Sequence analysis of the MS *vlhA* gene region has been used for the classification of strains and epidemiological studies and should be regarded as a preliminary typing method \[[@ref18]-[@ref20]\].

Concerning viral pathogens involved in arthritis, avian reovirus (ARV) has been recognized to be responsible for many cases of chicken viral arthritis/tenosynovitis among layer and broiler chickens in recent years \[[@ref21]\]. ARV infection is usually present in poultry flocks without clinical manifestations. However, it may be involved in several disease syndromes including viral arthritis or tenosynovitis, respiratory disease, enteric disease, stunting syndrome, immunosuppression, and malabsorption syndrome. Viral arthritis/tenosynovitis is the most important in broiler breeder chickens. ARV can induce arthritis or tenosynovitis either alone or in combination with other pathogens as MS, *Staphylococcus* spp., and *E. coli* \[[@ref22]-[@ref24]\]. The ARV genome consists of 10 segments of double-stranded RNA: Four small (S1, S2, S3, and S4), three medium (M1, M2, and M3), and three large (L1, L2, and L3) \[[@ref22]\]. Diagnosis of ARV is based on the detection of the virus in clinically affected joints which can be achieved by molecular techniques \[[@ref25]-[@ref30]\].

This study aimed to detect the possible pathogens involved in field cases of arthritis from breeder chicken flock with special reference to molecular identification of MS and ARV.

Materials and Methods {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

This study was approved by Ethical Committee for Medical Research at the National Research Centre, Egypt and in accordance with local laws and regulations.

Field samples {#sec2-2}
-------------

This study was carried out on broiler breeder flock of 57 weeks old located in Dakahlia, Egypt. Birds suffered from arthritis with a history of 5-7% decrease in egg production and decreased fertility and hatchability. Blood and joint samples were collected as follows:

Forty blood samples were collected randomly from individual birds with arthritis in sterile tubes and used for serum separation by centrifugation at 3000 rpm for 20 min. Sera were tested using SPA test for *Mycoplasma gallisepticum* (MG) and MS as well as *Salmonella gallinarum-pullorum* (SGP) against colored antigens obtained from Intervet Co., Boxmeer, Netherlands. Serum agglutination tests were carried out according to the National Poultry Improvement Plan \[[@ref31]\].Twenty-four joint samples (synovial fluid) were collected under aseptic conditions after disinfection of joint externally with alcohol. Due to the shortage and insufficiency of financial resources, samples were divided into two groups (each of 12 samples). Samples of the first group were subjected to bacteriological examination, while in second group, each sample was subsequently subdivided into two parts. One part was forwarded for reverse transcription PCR (RT-PCR) application for ARV diagnosis, and the other part was directed for PCR application for MS diagnosis.

Bacteriological examination {#sec2-3}
---------------------------

Aseptically collected joint samples in the first group, subjected to bacteriological examination, were inoculated into tryptic soy broth and incubated at 37°C for 18 h, then subcultured on to 5% sheep blood agar base, *Salmonella Shigell*a Agar, MacConkey agar, Eosin methylene blue agar, Mannitol salt agar, nutrient agar, and tryptic soy agar plates, and incubated at 37°C for 24-48 h. The obtained bacterial growth was purified and examined for colonial morphology and staining characteristics \[[@ref32]\] and subjected to biochemical identification \[[@ref33]-[@ref35]\]. *E. coli* and *Salmonella* spp. strains were serotyped using slide agglutination test against polyvalent and monovalent standard antisera obtained from Behring Werke Institute, Germany, using methods of Neville and Brgant \[[@ref36]\] and Lee and Arp \[[@ref37]\].

PCR for MS and ARV {#sec2-4}
------------------

### MS {#sec3-1}

Sample preparation

Aseptically collected joint samples were inoculated in pleuropneumonia-like organism (PPLO) broth. The inoculated media were incubated at 37°C in humid CO~2~ incubator for 24 h \[[@ref38]\]. The propagated bacteria were harvested by centrifugation at 14,000 g for 10 min, and microbial pellet was resuspended in 300 μl PBS for DNA extraction.

DNA extraction

The suspended bacterial pellet was subjected to DNA extraction using the QIAamp DNA Mini kit (Qiagen, Germany, GmbH) with modifications from the manufacturer's recommendations. Briefly, 200 µl of the sample suspension was incubated with 10 µl of proteinase K and 200 µl of lysis buffer at 56°C for 10 min. Then, 200 µl of 100% ethanol was added to the lysate. The precipitated nucleic acid was then washed and centrifuged. Extracted DNA was eluted with 100 µl of elution buffer provided in the kit.

PCR amplification

The PCR reaction mix was performed in a total volume of 25 μl per sample, containing 12.5 µl of EmeraldAmp Max PCR Master Mix (Takara, Japan), 1 µl of each primer of 20 pmol concentrations, 4.5 µl of deionized distilled water, and 6 µl of DNA template. The reaction was performed in an Applied Biosystems 2720 Thermal Cycler as follows: 5 min at 94°C, followed by 35 cycles of 30 s at 94°C, 40 s at 55°C, and 45 s at 72°C, with a final extension cycle of 10 min at 72°C, producing a fragment of 396 bp. Oligonucleotide primers supplied from Metabion, Germany, are listed in [Table-1](#T1){ref-type="table"}. The positive control was a commercially available MS isolate provided by Charles River Laboratories, Inc., USA, Batch 25121227A.

###### 

Oligonucleotides primers sequences, target genes, and amplicon sizes used in PCR.

  Target agent                    Target gene   Primer sequence (5'- 3')        Amplified segment (bp)   Reference
  ------------------------------- ------------- ------------------------------- ------------------------ -----------------------------
  MS                              *vlhA*        F: GATGCGTAAAATAAAAGGAT         396                      Hong *et al*. \[[@ref18]\]
  R: GCTTCTGTTGTAGTTGCTTC                                                                                
  ARV                             S2            REO-F: CCC ATG GCA ACG ATT TC   399                      Bruhn *et al*. \[[@ref26]\]
  REO-R: TTC GGC CAG GTC TCA AC                                                                          

PCR=Polymerase chain reaction, ARV=Avian reovirus, *vlhA=*Variable lipoprotein hemagglutinin A, MS=*Mycoplasma synoviae*

### ARV {#sec3-2}

Sample preparation

Twelve joint samples were subjected to centrifugation at 3000× g for 5 min and then filtrated through a sterile 0.22-μm membrane filter. The filtered supernatants were collected in a 1.5-ml sterile RNase- and DNase-free microtube and stored at −20°C until use for RNA extraction.

RNA extraction

Filtered joint samples were subjected to RNA extraction using the QIAamp Viral RNA Mini Kit (Qiagen, Germany, GmbH). Briefly, 140 µl of the filtered sample was incubated with 560 µl of AVL lysis buffer containing 5.6 µl of carrier RNA at room temperature for 10 min. After incubation, 560 µl of 100% ethanol was added to the lysate. The samples were then washed and centrifuged following the manufacturer's recommendations. Nucleic acid was eluted with 60 µl of elution buffer provided in the kit.

RT-PCR amplification

Amplification was performed in a total volume of 25 μl containing 12.5 µl of QuantiTect Probe RT-PCR Buffer (Qiagen, GmbH), 1 µl of each primer of 20 pmol concentration, 0.25 µl of rt-enzyme, 4.25 µl of water, and 6 µl of RNA template. The reaction was performed in a Biometra Thermal Cycler. Thermal conditions consisted of RT at 50°C for 30 min and then primary denaturation at 95°C for 5 min. These steps were followed by 35 cycles of 94°C for 30 s, 55°C for 45 s, and 72°C for 45 s. The last step was done at 72°C for 10 min, producing a fragment of 399 bp. Oligonucleotide primers supplied from Metabion, Germany, are listed in [Table-1](#T1){ref-type="table"}. The positive control was ARV field sample previously confirmed (to be positive for S2 gene) in reference laboratory for veterinary quality control on poultry production, Animal Health Research Institute.

MS and ARV analysis of the PCR products {#sec2-5}
---------------------------------------

The products of PCR were separated by electrophoresis on 1.5% agarose gel (Applichem, Germany, GmbH) in 1× TBE buffer at room temperature using gradients of 5 V/cm. For gel analysis, 15 µl of the products were loaded in each gel slot. A 100 bp DNA ladder (Qiagen, Germany, GmbH) was used to determine the fragment sizes. The gel was photographed by a gel documentation system (Alpha Innotech, Biometra), and the data were analyzed through computer software.

MS vlhA gene sequencing and phylogeny {#sec2-6}
-------------------------------------

Four PCR products of *vlhA* gene of MS isolates, named MS-2018D1, MS-2018D2, MS-2018D3, and MS-2018D4, were purified using QIAquick PCR Product Extraction Kit (Qiagen, Valencia). The sequence reaction was done by Bigdye Terminator V3.1 Cycle Sequencing Kit (Perkin-Elmer), and then, it was purified using Centrisep spin column. DNA sequences were performed by Applied Biosystems 3130 Genetic Analyzer (Hitachi, Japan). To establish sequence identity to GenBank accessions, a BLAST^®^ analysis (Basic Local Alignment Search Tool) \[[@ref39]\] was initially performed. The phylogenetic tree was obtained by the MegAlign module of Lasergene DNAStar \[[@ref40]\] and phylogenetic analyses were conducted with published data of other 22 isolates ([Table-2](#T2){ref-type="table"}) based on maximum likelihood, neighbor-joining, and maximum parsimony in MEGA6 \[[@ref41]\].

###### 

Published MS sequences of *vlhA* used for multiple alignment analysis.

  MS partial amplification of *vlhA* gene   GenBank accession no.                      Isolate name           Strain type                                               Country of origin
  ----------------------------------------- ------------------------------------------ ---------------------- --------------------------------------------------------- ---------------------
  1                                         CP021129.1                                 MS-H                   Vaccine strain                                            Australia
  2                                         CP012624.1                                 86079-7NS              The parent strain of temperature-sensitive MS-H vaccine   Australia: Victoria
  3                                         KP704286.1                                 MS-H                   Vaccine strain                                            Australia
  4                                         CP011096.1                                 WVU1853                Field strain                                              USA: West Virginia
  5                                         FJ890931.1                                 WVU 1853; ATCC 25204   Field strain                                              Tunisia
  6                                         AF035624.1                                 WVU-1853               Field strain                                              Australia
  7                                         HQ326479.1                                 WVU1853                Field strain                                              USA: West Virginia
  8                                         GU084388.1                                 ULB02/T6               Field strain                                              Slovenia
  9                                         GU084387.1                                 T65M/T3K2              Field strain                                              Slovenia
  10                                        GU084386.1                                 ULB02/OV6K1            Field strain                                              Slovenia
  11                                        GU084385.1                                 T65M/T3K1              Field strain                                              Slovenia
  12                                        GU084384.1                                 T68W/IP2K              Field strain                                              Slovenia
  13                                        GU084383.1                                 T68W/IT2B              Field strain                                              Slovenia
  14                                        GU084382.1                                 T68W/IT2A              Field strain                                              Slovenia
  15                                        GU451303.1                                 T68W/IT1A              Field strain                                              Slovenia
  16                                        HQ326477.1                                 MS173                  Field strain                                              Argentina
  17                                        HQ326476.1                                 MS117                  Field strain                                              Argentina
  18                                        AF085698.1                                 WUV-1853               Field strain                                              Australia
  19                                        AF085697.1                                 WVU-1853               Field strain                                              Australia
  20                                        AF464937.1                                 MS-H                   Vaccine strain                                            Australia
  21                                        AF464938.1                                 MS-H                   Vaccine strain                                            Australia
  22                                        AF464936.1                                 MS-H                   Vaccine strain                                            Australia
  23                                        MH605097[\*](#t2f1){ref-type="table-fn"}   MS-2018D1              Field strain                                              Egypt
  24                                        MH605098[\*](#t2f1){ref-type="table-fn"}   MS-2018D4              Field strain                                              Egypt
  25                                        MH605099[\*](#t2f1){ref-type="table-fn"}   MS-2018D2              Field strain                                              Egypt
  26                                        MH605100[\*](#t2f1){ref-type="table-fn"}   MS-2018D3              Field strain                                              Egypt

Indicates MS field isolates of the current study. *vlhA=*Variable lipoprotein hemagglutinin A, MS=*Mycoplasma synoviae*

Results and Discussion {#sec1-3}
======================

Locomotor disorders are a terrible challenge facing the poultry industry and represent a major economic and welfare problem. The most important locomotor affection is septic arthritis, which means a microbial infection of one or more joints \[[@ref42]\]. In Egypt, arthritis in broiler breeders causes high economic losses as a result of lameness accompanied by an inability to feed, resulting in loss of weight and even mortalities.

Multiple organisms can cause septic arthritis in poultry. The most important organisms are *Staphylococcus* spp., *E. coli*, *Salmonella* spp., *Enterococcus* spp., MS, in addition to ARV \[[@ref1],[@ref4]\].

MS is an important poultry pathogen, causing infectious synovitis and respiratory disease. MS infection can be diagnosed serologically by SPA test, which is considered as the initial qualitative screening test used for monitoring antibodies against the pathogen. Besides, it is also used for the screening of other pathogens such as MG and SGP in poultry flocks. The test is rapid, inexpensive with efficient sensitivity but low specificity \[[@ref14],[@ref24]\].

In our study, the tested sera by SPA test showed positive results for MG, MS, and SGP in rates of 14/40 (35%), 35/40 (87.5%), and 9/40 (22.5 %), respectively. The obtained results indicate the circulation of these bacteria among birds of the tested flock. These results fairly close to that obtained by Amer and El-Ghany \[[@ref43]\] who reported that the prevalence of MG and MS was 44.35% and 63%, respectively, in breeder chicken flocks by SPA test but differ than that obtained by Silva *et al*. \[[@ref44]\] who reported negative results for *Salmonella pulloru*m, *Salmonella gallinarum*, and MG and only positive results (2/135, 1.48%) for MS using SPA test.

Bacteriological examination of joint samples revealed identification of 19 bacterial isolates through morphological and biochemical characterization of grown bacteria. The isolated bacteria were five *Staphylococcus* spp. isolates, nine *E. coli* isolates, three SGP isolates, one *Citrobacter*, and one *Proteus*. The *Staphylococci* isolates were identified into three coagulase-positive *Staphylococcus* (two *Staphylococcus aureus* and one *Staphylococcus hyicus*) and two coagulase-negative staphylococci (one *Staphylococcus epidermidis* and one *Staphylococcus lentus*). *E. coli* isolates were serotyped into one O11, two O55, three O78, one O124, one O125, and one untyped. These results are similar to those reported by Nazia *et al*. \[[@ref42]\], Rasheed \[[@ref45]\], Braga *et al*. \[[@ref46]\], and Tawfik *et al*. \[[@ref47]\] who isolated *E. coli, S. aureus, Salmonella Enterica, Pseudomonas aeruginosa*, and *Erysipelothrix rhusiopathiae* from hock joint.

The study targeted MS and ARV as major infectious causes of leg problems emerging at the broiler breeder level and also characterized by their vertical transmission \[[@ref24]\]. The nature of MS is being a fastidious organism needs special nutritional requirements, thus its culturing and isolation is not preferred for flock screening due to its difficulty and time-consuming. To control the infection and subsequently limit economic losses in poultry industry, obstacles of traditional isolation of MS were overcome through the application of early, rapid, and accurate diagnostic methods as PCR for the detection and diagnosis \[[@ref19],[@ref48],[@ref49]\].

In our study, PCR for MS identification was applied after 24 h of cultivation in PPLO broth as application of PCR on MS inoculated and incubated PPLO broth 24-48 h was of a higher rate than those applied directly on joint samples. This might be due to MS propagation which improves the detection limit of PCR. Moreover, more reduction of PCR inhibitor was from PPLO broth than from tissue samples \[[@ref38],[@ref50],[@ref51]\].

The RT-PCR for S2 gene of ARV was negative for all examined samples as shown in [Figure-1](#F1){ref-type="fig"}. On the other hand, PCR for *vlhA* gene of MS revealed the presence of 12/12 (100%) positive samples as shown in [Figure-2](#F2){ref-type="fig"}. Our results were opposite to those obtained by Souza *et al*. \[[@ref30]\] who found that all examined samples were positive for ARV and negative for MS and MG by PCR. Furthermore, the results were different from that obtained by Reck *et al*. \[[@ref52]\] who detected MS in 61.79% (131/212), ARV in 25.47% (54/212), and both MS and ARV in 18.86% (40/212) of examined samples of tibiotarsal articulation of broiler chickens by multiplex PCR.

![Amplified S2 gene of avian reovirus. Lane L = 100 bp marker; Lanes 1-4 = Examined samples; Lane Neg = Negative control; Lane Pos = Positive control.](VetWorld-12-535-g001){#F1}

![Amplified *vlhA* gene of *Mycoplasma synoviae*. Lane L = 100 bp marker; Lanes 1-4 = Examined samples; Lane Neg = Negative control; Lane Pos = Positive control.](VetWorld-12-535-g002){#F2}

The successfully amplified *vlhA* gene of four MS isolates, named MS-2018D1, MS-2018D2, MS-2018D3, and MS-2018D4, was sequenced and submitted to NCBI GenBank and the obtained accession numbers are MH605097, MH605099, MH605100, and MH605098, respectively.

As this broiler breeder flock is not vaccinated against MS, so alignment of amplified products of four field isolates with vaccine strain (MS-H) and other published *vlhA* sequence ([Table-2](#T2){ref-type="table"}) was applied. Phylogenetic tree analysis according to sequences of *vlhA* gene showed 100% homology between sequenced isolates MS-2018D1 and MS-2018D4 and also between isolates MS-2018D2 and MS-2018D3 of the current study; this may be due to the same source of infection. While isolates MS-2018D1 and MS-2018D4 showed the same nucleotide similarity (88.6%) when compared with isolates MS-2018D2 and MS-2018D3.

Egyptian field isolates MS-2018D1, MS-2018D4, MS-2018D2, and MS-2018D3 had 98.4%, 98.4%, 88.1%, and 88.1% nucleotide identity with vaccine strain MS-H, respectively. Furthermore, the four Egyptian isolates had similarities 87.8-98.6% with field strains from Argentina, while the identity was 77.0-92.7% with other field isolates from Tunisia, Australia, USA, and Slovenia (Figures-[3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}).

![Phylogenetic tree of *Mycoplasma synoviae* based on the nucleotide sequence of *vlhA* gene. Branched distances correspond to sequence divergence.](VetWorld-12-535-g003){#F3}

![Percentage of nucleotide identities for the *vlhA* genes of four MS strains named MS-2018D1, MS-2018D2, MS-2018D3, and MS-2018D4 as compared with 22 sequences published in GenBank.](VetWorld-12-535-g004){#F4}

Conclusion {#sec1-4}
==========

Four field isolates of MS were identified in the examined broiler breeder flock. A phylogenetic study of these isolates showed the presence of variation between isolated field MS strains and vaccine strain. Hence, further studies are recommended to detect the vaccine efficacy against the present field isolates of MS. Implementation of proper MS immunization program is important for breeder flocks in order to control the disease.
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